GlassScriptPhysician profile
Laura J Kota
NPI 1649299223
$1,745.51
in general payments reported to CMS, 2019-2025
29 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $254 · 2021: $352 · 2022: $221 · 2023: $228 · 2024: $215 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620 · Education: $17.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.50 |
| Education | $17.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $379.16 | 2019-2023 | |
| Hologic Sales and Service, LLC | $174.50 | 2019-2024 | Acessa Provu System, Fluent Fluid Management System |
| Aspira Women'S Health INC | $150.10 | 2020-2021 | |
| Eisai INC. | $107.16 | 2025 | |
| Biogen, INC. | $78.58 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $77.90 | 2019-2022 | |
| Pfizer INC. | $75.99 | 2021-2023 | |
| Therapeuticsmd, INC. | $75.59 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $68.95 | 2023 | Myfembree |
| Covidien LP | $67.66 | 2019-2020 | |
| Lupin INC. | $66.85 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $40.91 | 2021-2022 | |
| Coloplast Corp | $37.90 | 2023-2024 | Restorelle |
| Agile Therapeutics, INC. | $37.57 | 2022 | |
| Exeltis, USA INC. | $35.10 | 2022-2025 | Slynd |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $34.68 | 2019-2020 | |
| Minerva Surgical, INC | $32.47 | 2020 | |
| Organon LLC | $29.97 | 2022-2024 | |
| Integra Lifesciences Corporation | $23.28 | 2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Exact Sciences Corporation | $19.92 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $18.58 | 2022 | |
| Coopersurgical, INC. | $18.41 | 2020 | |
| Heron Therapeutics, INC. | $16.50 | 2022 | |
| Scynexis, INC. | $16.00 | 2022 | |
| Octapharma USA, INC. | $15.62 | 2025 | Fibryga |
| Amag Pharmaceuticals, INC. | $12.80 | 2019 | |
| Amgen INC. | $11.36 | 2019 | |
| Merck Sharp & Dohme LLC | $11.08 | 2019 | |
| Roche Diagnostics Corporation | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Kota listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.